1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
fax: 507-266-4531.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Autoimmune, Cholestatic, and Biliary Disease
You have full text access to this OnlineOpen article
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis†
Article first published online: 20 MAY 2009
DOI: 10.1002/hep.23082
Copyright © 2009 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Mooney, J., Sargeant, C., Braaten, J., Bernard, T., King, D., Miceli, E., Schmoll, J., Hoskin, T., Thapa, P. and Enders, F. (2009), High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology, 50: 808–814. doi: 10.1002/hep.23082
- †
Potential conflicts of interest: none.
Publication History
- Issue published online: 27 AUG 2009
- Article first published online: 20 MAY 2009
- Accepted manuscript online: 20 MAY 2009 12:00AM EST
- Manuscript Accepted: 11 MAY 2009
- Manuscript Received: 19 MAR 2009
Funded by
- National Institute of Diabetes and Digestive and Kidney Diseases. Grant Number: 56924
- Axcan Pharma
- National Center for Research Resources (awarded to Virginia Commonwealth University). Grant Number: M01RR000065
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , A 42–Year–Old Woman With a New Diagnosis of Sclerosing Cholangitis, Clinical Gastroenterology and Hepatology, 2012, 10, 6, 593
- 2, , , , , , , Biliary Atresia in The Netherlands: Outcome of Patients Diagnosed between 1987 and 2008, The Journal of Pediatrics, 2012, 160, 4, 638
- 3, , Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis – authors’ reply, Alimentary Pharmacology & Therapeutics, 2012, 35, 7Direct Link:
- 4, Diagnostic and therapeutic challenges in pediatric primary sclerosing cholangitis, Liver Transplantation, 2012, 18, 3Direct Link:
- 5, , , Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review, Journal of Hepatology, 2012, 56, 5, 1181
- 6, , , , Evolving concepts in primary sclerosing cholangitis, Liver International, 2012, 32, 3Direct Link:
- 7, , , FXR and PXR: Potential therapeutic targets in cholestasis, The Journal of Steroid Biochemistry and Molecular Biology, 2012, 130, 3-5, 147
- 8, , , , , , , , , Hepatopancreatobiliary manifestations of inflammatory bowel disease, Clinical Journal of Gastroenterology, 2012, 5, 1, 1
- 9, , , , , , , , , , , , , High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia, Alimentary Pharmacology & Therapeutics, 2012, 35, 4Direct Link:
- 10, , Primary sclerosing cholangitis: providing a safe and effective treatment, Expert Review of Gastroenterology & Hepatology, 2012, 6, 3, 255
- 11, , PSC, AIH and overlap syndrome in inflammatory bowel disease, Clinics and Research in Hepatology and Gastroenterology, 2012,
- 12, , , , , , Response to the letter by Ooi et al., Journal of Cystic Fibrosis, 2012, 11, 1, 74
- 13, , , , SÃndrome de superposición de hepatitis autoinmune y colangitis esclerosante primaria en adultos: reporte de tres casos, GastroenterologÃa y HepatologÃa, 2012, 35, 4, 254
- 14, , , , Serum lipids in primary sclerosing cholangitis, Digestive and Liver Disease, 2012, 44, 1, 44
- 15, , , , , , , , , , , , The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis – a pilot study, Alimentary Pharmacology & Therapeutics, 2012, 35, 2Direct Link:
- 16, , , , Ursodeoxycholic acid in cystic fibrosis-associated liver disease, Journal of Cystic Fibrosis, 2012, 11, 1, 72
- 17, , , , , , , Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: Long-term results, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 2, 146
- 18
- 19
- 20
- 21
- 22
- 23
- 24, , , , , , , , , , , , , , A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis, Journal of Hepatology, 2011, 54, 5, 1011
- 25, ABCB4 Disease Presenting with Cirrhosis and Copper Overload-Potential Confusion with Wilson Disease, Journal of Clinical and Experimental Hepatology, 2011, 1, 2, 115
- 26, , , , , , Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis, Digestive and Liver Disease, 2011, 43, 4, 309
- 27, Autoimmune hepatitis in special patient populations, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 689
- 28, , Autoimmune liver diseases in children – What is different from adulthood?, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 783
- 29, , , Cancer surveillance in patients with primary sclerosing cholangitis, Hepatology, 2011, 54, 5Direct Link:
- 30, Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento, GastroenterologÃa y HepatologÃa, 2011, 34, 1, 41
- 31, , , , Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct–ligated rats and human hepatic cells, Hepatology, 2011, 53, 2Direct Link:
- 32, , Current consensus on the management of primary sclerosing cholangitis, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 12, 786
- 33, , Current Management of Primary Sclerosing Cholangitis in Pediatric Patients, Pediatric Drugs, 2011, 13, 2, 87
- 34, Hepatobiliary Complications of Inflammatory Bowel Disease, Current Gastroenterology Reports, 2011, 13, 5, 495
- 35, , , Hepatobiliary disorders and complications of inflammatory bowel disease, Journal of Digestive Diseases, 2011, 12, 4Direct Link:
- 36, , Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders, Clinics in Liver Disease, 2011, 15, 1, 89
- 37, , , , , , , , , , , , , High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis, The American Journal of Gastroenterology, 2011, 106, 9, 1638
- You have free access to this content38, , , , , , , , , , , , , , , High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis, Alimentary Pharmacology & Therapeutics, 2011, 34, 10Direct Link:
- 39
- 40, Keith D. Lindor, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 6-7, 423
- 41, , Medical and endoscopic therapy of primary sclerosing cholangitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 741
- 42, , , , , Medical management of motility disorders in patients with intestinal failure: a focus on necrotizing enterocolitis, gastroschisis, and intestinal atresia, Journal of Pediatric Surgery, 2011, 46, 8, 1618
- 43, , Medical therapy for primary sclerosing cholangitis, Alimentary Pharmacology & Therapeutics, 2011, 34, 9Direct Link:
- 44, , , , Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis, Alimentary Pharmacology & Therapeutics, 2011, 34, 8Direct Link:
- 45, New Treatment Strategies for Primary Sclerosing Cholangitis, Digestive Diseases, 2011, 29, 1, 113
- 46, Novel developments in IBD-related sclerosing cholangitis, Best Practice & Research Clinical Gastroenterology, 2011, 25, S15
- 47
- 48, Primary sclerosing cholangitis is changing clinical spectrum and old biomarkers disclose an innovative role: The case of alkaline phosphatase, Digestive and Liver Disease, 2011, 43, 4, 268
- 49, , Primary Sclerosing Cholangitis: Is Any Treatment Worthwhile?, Current Gastroenterology Reports, 2011, 14, 1, 17
- 50, , , , , Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2011, 34, 5Direct Link:
- 51, , , , , , , , Sclerosing Cholangitis after Transcatheter Arterial Chemoembolization: a Case Report, Chinese Medical Sciences Journal, 2011, 26, 3, 190
- 52, , Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4-associated cholangitis and overlap with autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2011, 33, 12Direct Link:
- 53, , , , , , The Spectrum of Sclerosing Cholangitis and the Relevance of IgG4 Elevations in Routine Practice, The American Journal of Gastroenterology, 2011, 107, 1, 56
- 54, , , , , , Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications, Clinical Science, 2011, 121, 12, 523
- 55
- 56
- 57, A zsÃrmáj szerepe a metabolikus szindróma kialakulásában, Orvosi Hetilap, 2010, 151, 35, 1430
- 58, , , , , , Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression, Hepatology, 2010, 52, 1Direct Link:
- 59
- 60, Biliary physiology and disease: Reflections of a physician-scientist, Hepatology, 2010, 51, 4Direct Link:
- 61, , , , , , , Childhood Autoimmune Liver Disease: Indications and Outcome of Liver Transplantation, Journal of Pediatric Gastroenterology and Nutrition, 2010, 50, 3, 295
- You have free access to this content62, , , , , , , Diagnosis and management of primary sclerosing cholangitis, Hepatology, 2010, 51, 2Direct Link:
- 63, , , , , Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment, Gastrointestinal Endoscopy, 2010, 71, 3, 527
- 64, , , , , Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM, Molecular Biology Reports, 2010, 38, 5, 3075
- 65, , Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease, Inflammatory Bowel Diseases, 2010, 16, 9Direct Link:
- 66, High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis, Yearbook of Medicine, 2010, 2010, 465
- 67, High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis, Yearbook of Gastroenterology, 2010, 2010, 240
- 68, , , , , , In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival, Journal of Hepatology, 2010, 53, 2, 313
- 69, , Ist hochdosierte Ursodeoxycholsäure bei nichtalkoholischer Steatohepatitis effektiv?, Der Gastroenterologe, 2010, 5, 6, 538
- 70, , , Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches, Gastroenterology, 2010, 139, 5, 1481
- 71, , Pediatric Inflammatory Bowel Disease in the Emergency Department, Clinical Pediatric Emergency Medicine, 2010, 11, 3, 189
- 72, Pharmacotherapy of cholestatic liver diseases, Journal of Digestive Diseases, 2010, 11, 3Direct Link:
- 73, , , Primary sclerosing cholangitis, Best Practice & Research Clinical Gastroenterology, 2010, 24, 5, 655
- 74, , Primary sclerosing cholangitis: overview and update, Nature Reviews Gastroenterology & Hepatology, 2010,
- 75, Primary sclerosing cholangitis: What is the role of ursodeoxycholic acid in therapy for PSC?, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 2, 74
- 76, , Sclerosing Cholangitis: Pediatric Perspective, Current Gastroenterology Reports, 2010, 12, 3, 195
- 77, , , , , , , , , , , , , , , The predictors of the presence of varices in patients with primary sclerosing cholangitis, Hepatology, 2010, 51, 4Direct Link:
- 78, , Treatment options for primary sclerosing cholangitis, Expert Review of Gastroenterology & Hepatology, 2010, 4, 4, 473
- 79, , , Update on primary sclerosing cholangitis, Digestive and Liver Disease, 2010, 42, 6, 390
- You have free access to this content80, High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: Throwing the urso out with the bathwater?, Hepatology, 2009, 50, 3Direct Link:
- 81, , Autoimmune Liver Diseases,Direct Link:
- 82, , , , Bile acids for primary sclerosing cholangitis, The Cochrane Library,Direct Link:
- 83, , Biliary Atresia and Cystic Fibrosis: Transitioning Care from Pediatrics to Internal Medicine,Direct Link:
- 84, Cholestatic and Autoimmune Liver Disease,Direct Link:
- 85, , Is there Still a Role for Ursodeoxycholic Acid Treatment in Patients with Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis?,Direct Link:
- 86, , Primary sclerosing cholangitis,Direct Link:
- 87, , , Primary Sclerosing Cholangitis,Direct Link:
- 88, , , Primary Sclerosing Cholangitis,Direct Link:
- 89, , Recurrent Disease Following Liver Transplantation,Direct Link:
- 90, , Sclerosing Cholangitis,Direct Link: